168681-96-7

Basic information

• Product Name: (R)-4-TERT-BUTOXY-2-(CYCLOHEXYLMETHYL)-4-OXOBUTANOIC ACID
• Synonyms: (R)-4-TERT-BUTOXY-2-(CYCLOHEXYLMETHYL)-4-OXOBUTANOIC ACID
• CAS NO: 168681-96-7
• Molecular Formula: C₁₅H₂₆O₄
• Molecular Weight: 270.36
• Mol File: 168681-96-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (R)-4-TERT-BUTOXY-2-(CYCLOHEXYLMETHYL)-4-OXOBUTANOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-TERT-BUTOXY-2-(CYCLOHEXYLMETHYL)-4-OXOBUTANOIC ACID(168681-96-7)
• EPA Substance Registry System: (R)-4-TERT-BUTOXY-2-(CYCLOHEXYLMETHYL)-4-OXOBUTANOIC ACID(168681-96-7)

Safety Data

• Hazardous Substances Data: 168681-96-7(Hazardous Substances Data)

Upstream product

• 122225-33-6 (2R)-3-tert-Butyloxycarbonyl-2-phenylmethylpropionic Acid 

Relevant articles and documents

Matrix metalloprotease inhibitors

Compounds of formula (I): STR1 as single stereoisomers or mixtures thereof and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as interstitial collagenases, and are useful in the treatment of mammals having disease states alleviated by the inhibition of such matrix metalloproteases, for example arthritic diseases or bone resorption disease, such as osteoporosis.

Matrix metalloprotease inhibitors

Compounds of formula (I) and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as stromelysin, gelatinase, matrilysin and collagenase, and are useful in the treatment of mammals having disease-states alleviated by the inhibition of such matrix metalloproteases.

MATRIX METALLOPROTEASE INHIBITORS

Compounds of formula (I): STR1 as single stereoisomers or mixtures thereof and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as interstitial collagenases, and are useful in the treatment of mammals having disease states alleviated by the inhibition of such matrix metalloproteases, for example arthritic diseases or bone resorption diseases, such as osteoporosis.